MedPath

Role of Homoeopathy in the treatment of chronic urticaria

Not Applicable
Conditions
Health Condition 1: L50- Urticaria
Registration Number
CTRI/2022/06/043474
Lead Sponsor
Bakson Homoeopathic Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Age 18 to 59 years

2 Both male and female

3 Patients of chronic Urticaria more than 6 weeks duration of suffering

4 Patients suffering from chronic urticaria diagnosis as per EAACI GA2LEN EDF WAO International Guidelines for urticaria

5 wheal in patients with urticaria has 3 typical features

6 a central swelling of variable size almost invariably surrounded by reflex erythema

7 an itching or sometimes burning sensation

A fleeting nature with the skin returning to its normal appearance usually within 30 minutes to 24 hours

8 Angioedema in urticaria patients is characterized by

A sudden pronounced erythematous or skin color swelling of the lower dermis and subcutis or mucous membrane

9 Sometimes pain rather than itching.

A resolution slower than that of wheals (can take up to 72 hours

10 Patients already on allopathic medication or topical agents for chronic urticaria will be included after a washout period of 15 days

Exclusion Criteria

1 Below 18 years and above 59 years

2 Acute Urticaria less than 6 weeks of suffering

3 Alcohol or drug addiction

4 Angioedema with no urticaria

5 Urticarial vasculitis

6 Maculopapular drug eruption

7 Contact dermatitis

8 Urticaria pigmentosa

9 Pregnant and lactating women

10 Patients with psychiatric diseases, and those who are not able to comply with the study protocol

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
There will be difference between result of Centesimal potencies and Fifty millesimal potencies which are used in managing the cases of chronic urticariaTimepoint: follow up in 15 days
Secondary Outcome Measures
NameTimeMethod
There will be reduction in UAS 7 score <br/ ><br>Timepoint: follow up in every 15 days
© Copyright 2025. All Rights Reserved by MedPath